BRIEF published on 02/02/2026 at 17:15, 25 days 12 hours ago Piramal Pharma Solutions Unveils Tablet-in-Capsule Technology Drug Delivery Piramal Pharma Tablet-in-Capsule Patient Centricity Customized Dosing
BRIEF published on 02/02/2026 at 17:15, 25 days 12 hours ago Piramal Pharma Solutions dévoile une technologie de comprimés en capsule. Administration De Médicaments Centré Sur Le Patient Piramal Pharma Comprimé En Capsule Dosage Personnalisé
PRESS RELEASE published on 02/02/2026 at 17:10, 25 days 12 hours ago Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities Piramal Pharma Solutions successfully develops tablet-in-capsule drug delivery system, offering flexible dosing options for oral therapies. Enhancing patient-centric solutions Drug Delivery System Patient-centric Piramal Pharma Solutions Tablet-in-Capsule Flexible Dosing Options
BRIEF published on 12/15/2025 at 07:10, 2 months 12 days ago Piramal Pharma Solutions Achieves High Net Promoter Score Operational Excellence Net Promoter Score Customer Loyalty Piramal Pharma Competitive Positioning
BRIEF published on 12/15/2025 at 07:10, 2 months 12 days ago Piramal Pharma Solutions obtient un score de recommandation client élevé Excellence Opérationnelle Fidélité Client Piramal Pharma Score Net De Promoteur Positionnement Concurrentiel
PRESS RELEASE published on 12/15/2025 at 07:05, 2 months 12 days ago Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score Piramal Pharma Solutions achieves impressive Net Promoter Score (NPS) of 55, surpassing industry averages, reflecting commitment to excellence and stakeholder centricity Operational Excellence Net Promoter Score Piramal Pharma Solutions NPS Stakeholder Centricity
BRIEF published on 11/26/2025 at 20:30, 3 months 1 day ago Piramal Pharma Solutions Ensures Compliance with Nitrosamine Regulations Regulatory Standards Piramal Pharma Solutions Nitrosamine Compliance Pharmaceutical Safety Testing Capabilities
BRIEF published on 11/26/2025 at 20:30, 3 months 1 day ago Piramal Pharma Solutions garantit la conformité aux réglementations sur les nitrosamines Normes Réglementaires Sécurité Pharmaceutique Conformité Aux Nitrosamines Capacités De Test Solutions Pharmaceutiques Piramal
PRESS RELEASE published on 11/26/2025 at 20:25, 3 months 1 day ago Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities Piramal Pharma Solutions achieves regulatory compliance for nitrosamine impurities, ensuring safety & adherence to global guidelines, enhancing capabilities & operational excellence Regulatory Compliance Operational Excellence Patient Safety Piramal Pharma Solutions Nitrosamine Impurities
BRIEF published on 11/19/2025 at 09:00, 3 months 8 days ago Piramal Pharma's Grangemouth Facility Secures Updated MHRA GMP Certifications ADC Development GMP Certification MHRA Approval Piramal Pharma Grangemouth Facility
Published on 02/28/2026 at 03:00, 2 hours 41 minutes ago Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 3 hours 41 minutes ago Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 5 hours 31 minutes ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/27/2026 at 23:30, 6 hours 11 minutes ago 55 North Mining Announces Closing of Flow-Through Financing
Published on 02/27/2026 at 19:30, 10 hours 11 minutes ago EUROPLASMA: Modification des caractéristiques des tranches 22 et 23 d’OCABSA
Published on 02/27/2026 at 17:59, 11 hours 42 minutes ago EQS-Adhoc: 4finance completes sale of TBI Bank to Advent International
Published on 02/27/2026 at 23:00, 6 hours 41 minutes ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 23:00, 6 hours 41 minutes ago Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 11 hours 38 minutes ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 18:02, 11 hours 38 minutes ago AXA: Conclusion d’une convention de rachat d’actions dans le cadre du programme de rachat d’actions d’AXA
